[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

AngioDynamics Inc (ANGO) - Financial and Strategic SWOT Analysis Review

October 2021 | 57 pages | ID: AF03A9F3C1FEN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
AngioDynamics Inc (ANGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimal invasive and image-guided therapeutics and diagnostic devices. Its product portfolio encompasses vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. Its products find application in interventional radiology, interventional cardiology, and minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. The company sells its products through direct sales force in the US and through a network of distributors outside the US. AngioDynamics is headquartered in Latham, New York, the US.

AngioDynamics Inc Key Recent Developments

Jul 13,2021: AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results
Apr 05,2021: AngioDynamics to Present at the Needham Virtual Healthcare Conference
Mar 30,2021: AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance
Mar 09,2021: AngioDynamics to Report Fiscal 2021 Third Quarter Financial Results on March 30, 2021
Mar 09,2021: AngioDynamics to Participate in a Virtual Fireside Chat at the Oppenheimer Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

AngioDynamics Inc - Key Facts
AngioDynamics Inc - Key Employees
AngioDynamics Inc - Key Employee Biographies
AngioDynamics Inc - Major Products and Services
AngioDynamics Inc - History
AngioDynamics Inc - Company Statement
AngioDynamics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
AngioDynamics Inc - Business Description
Product Category: Endovascular Therapies
Overview
Performance
Product Category: Oncology/Surgery
Overview
Performance
Product Category: Vascular Access
Overview
Performance
Geographical Segment: International
Performance
Geographical Segment: The US
Performance
R&D Overview
AngioDynamics Inc - Corporate Strategy
AngioDynamics Inc - SWOT Analysis
SWOT Analysis - Overview
AngioDynamics Inc - Strengths
AngioDynamics Inc - Weaknesses
AngioDynamics Inc - Opportunities
AngioDynamics Inc - Threats
AngioDynamics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

AngioDynamics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
AngioDynamics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
AngioDynamics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jul 13, 2021: AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results
Apr 05, 2021: AngioDynamics to Present at the Needham Virtual Healthcare Conference
Mar 30, 2021: AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance
Mar 09, 2021: AngioDynamics to Report Fiscal 2021 Third Quarter Financial Results on March 30, 2021
Mar 09, 2021: AngioDynamics to Participate in a Virtual Fireside Chat at the Oppenheimer Healthcare Conference
Mar 01, 2021: AngioDynamics to Present at the Barclays Virtual Global Healthcare Conference
Feb 01, 2021: AngioDynamics appoints Richard C. Rosenzweig Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs February 1st, 2021 Announcements
Jan 07, 2021: AngioDynamics reports fiscal 2021 second quarter financial results
Jan 04, 2021: AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference
Sep 29, 2020: AngioDynamics reports fiscal 2021 first quarter financial results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

AngioDynamics Inc, Key Facts
AngioDynamics Inc, Key Employees
AngioDynamics Inc, Key Employee Biographies
AngioDynamics Inc, Major Products and Services
AngioDynamics Inc, History
AngioDynamics Inc, Other Locations
AngioDynamics Inc, Subsidiaries
AngioDynamics Inc, Key Competitors
AngioDynamics Inc, Ratios based on current share price
AngioDynamics Inc, Annual Ratios
AngioDynamics Inc, Annual Ratios (Cont...1)
AngioDynamics Inc, Annual Ratios (Cont...2)
AngioDynamics Inc, Interim Ratios
AngioDynamics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
AngioDynamics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
AngioDynamics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

AngioDynamics Inc, Performance Chart (2017 - 2021)
AngioDynamics Inc, Ratio Charts
AngioDynamics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
AngioDynamics Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021


More Publications